Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05349162
Other study ID # 134526
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2003
Est. completion date April 1, 2022

Study information

Verified date April 2022
Source Paris Cardiovascular Research Center (Inserm U970)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This observational study included all patients <18-year-old implanted with an Implantable cardioverter defibrillator (ICD) at Necker Hospital, Paris, France, from January 2003 to January 2021. Outcomes (ICD-related complications and reinterventions) were compared between epicardial and transvenous ICDs using Cox proportional hazard models.


Recruitment information / eligibility

Status Completed
Enrollment 131
Est. completion date April 1, 2022
Est. primary completion date January 1, 2021
Accepts healthy volunteers
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - ICD implantation - Age < 18 years Exclusion Criteria: - Absence of patient's consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Implantable cardioverter defibrillator use
Implantation of an implantable cardioverter defibrillator (epicardial or transvenous)

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Paris Cardiovascular Research Center (Inserm U970) Hôpital Necker-Enfants Malades

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with implantable cardioverter defibrillator system dysfunction (lead dysfunction requiring reintervention) Number of patients in each group (epicardial and transvenous implantable cardioverter defibrillator) with an implantable cardioverter defibrillator dysfunction (dysfunction of at least one lead requiring reintervention) at the end of the follow-up up to 15 years
See also
  Status Clinical Trial Phase
Terminated NCT02243696 - Protego DF4 Post Approval Registry
Completed NCT02902458 - Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study N/A
Recruiting NCT02058771 - Utilising Lifemap to Investigate Malignant Arrhythmia Therapy
Completed NCT02232204 - Sleep and Ventricular Arrhythmias Study Phase 2
Recruiting NCT05302115 - S-ICD French Cohort Study (HONEST)
Completed NCT05101720 - Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI TRIAL N/A
Active, not recruiting NCT03884608 - Analysis of Both Sex and Device Specific Factors on Outcomes in Patients With Non-Ischemic Cardiomyopathy
Completed NCT02787291 - A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study N/A
Completed NCT02064192 - Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe
Terminated NCT03103503 - Plexa ICD Lead Registry
Recruiting NCT05855135 - Assessment of Combined CCM and ICD Device in HFrEF N/A
Not yet recruiting NCT06388382 - Investigation of the Audible ICD Alert Tone
Recruiting NCT04858672 - Shock Testing to Unmask RV Lead and GEnerator Malfunction in ICD Patients: the SURGE-ICD Registry
Completed NCT03209726 - Assessment of S-ICD Eligibility With 12-Lead ECG
Active, not recruiting NCT04981496 - Novel ICD Arrhythmia Detection Algorithm
Recruiting NCT05645965 - Association of Obesity and Cardiovascular Outcomes in Patients With Implantable Cardioverter-defibrillator (ICD)
Completed NCT03544489 - Implementing Exercise After an (ICD) N/A
Completed NCT03210883 - Global Electrical Heterogeneity and Clinical Outcomes
Completed NCT02491853 - The Gulf Implantable Cardioverter-Defibrillator Registry N/A
Completed NCT01944514 - Implantable Cardioverter Defibrillators - Improving Risk Stratification N/A